Latest: FDA Approves New Biosimilar for Oncology Treatment

Frontline Immunotherapy May Offer Best Chance to Cure Kidney Cancer

0 Mins
Clinical trials still have a role in improving outcomes with immunotherapy among those with kidney cancer.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago